Science Explorer Back to mapMap
Discussion
Company · Saarbrücken · Germany

URSAPHARM (Germany)

ursapharm.de/en/homeROR OpenAlex
Research works
16
▼ 25% vs 2018-21
Citations
211
13.0 per fractional work
Top-10% rate
8.7%
all institutions 10.0%
Open access
60%
world 40%
International
25%
world 18%
URSAPHARM (Germany)

Not ranked overall: URSAPHARM (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does URSAPHARM (Germany) work in?

In all years, 67% of research at URSAPHARM (Germany) is in Health Sciences, 27% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (21%), Neuroscience (3%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 11 fractional works · 66.7% of its workMedicine: 11 fractional works · 66.3% of its workInfectious Diseases: 1 fractional works · 9.0% of its workImmunology and Allergy: 1 fractional works · 7.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 6.8% of its workSurgery: 1 fractional works · 6.2% of its workBiochemistry: 1 fractional works · 5.5% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 4.8% of its workOphthalmology: 1 fractional works · 4.2% of its workOtorhinolaryngology: 1 fractional works · 4.1% of its workOncology: 0 fractional works · 2.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.7% of its workPhysiology: 0 fractional works · 2.6% of its workHematology: 0 fractional works · 2.0% of its workPharmacology: 0 fractional works · 2.0% of its workDermatology: 0 fractional works · 1.7% of its workEpidemiology: 0 fractional works · 1.4% of its workComplementary and alternative medicine: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.7% of its workUrology: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workLife Sciences: 4 fractional works · 26.8% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 20.9% of its workMolecular Biology: 3 fractional works · 19.2% of its workCell Biology: 0 fractional works · 1.0% of its workCancer Research: 0 fractional works · 0.7% of its workNeuroscience: 1 fractional works · 3.3% of its workSensory Systems: 0 fractional works · 2.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workImmunology and Microbiology: 0 fractional works · 2.0% of its workMicrobiology: 0 fractional works · 2.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workToxicology: 0 fractional works · 0.6% of its workPhysical Sciences: 1 fractional works · 6.5% of its workChemistry: 0 fractional works · 2.7% of its workSpectroscopy: 0 fractional works · 2.0% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 1.4% of its workAutomotive Engineering: 0 fractional works · 0.7% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workMaterials Science: 0 fractional works · 1.2% of its workMaterials Chemistry: 0 fractional works · 0.9% of its workBiomaterials: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workEnergy: 0 fractional works · 0.5% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.2% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.2% of its workALL ITS WORKURSAPHARM(Germany)16fractional works, all years
Life Sciences27%Physical Sciences6%Health Sciences67%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 12 fields, with their numbers
    1. Medicine1166.3%
    2. Nursing00.5%
    1. Biochemistry, Genetics and Molecular Biology320.9%
    2. Neuroscience13.3%
    3. Immunology and Microbiology02.0%
    4. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Chemistry02.7%
    2. Engineering01.4%
    3. Materials Science01.2%
    4. Computer Science00.5%
    5. Energy00.5%
    6. Environmental Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.57× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 1.24× its world share, 0 worksNeuroscienceComputer Science: 0.32× its world share, 0 worksComputer ScienceEngineering: 0.45× its world share, 0 worksEngineeringMaterials Science: 0.96× its world share, 0 worksMaterials ScienceMedicine: 4.01× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Medicine4.01×3 works
  2. Biochemistry, Genetics and Molecular Biology1.57×0 works
  3. Neuroscience1.24×0 works
  4. Materials Science0.96×0 works
  5. Engineering0.45×0 works
  6. Computer Science0.32×0 works

Who are the top researchers at URSAPHARM (Germany)?

Ranked on the quality score, Peter Meiser and Dorothea Groß lead among researchers whose main affiliation is URSAPHARM (Germany).

  1. 1 Peter Meiser Germany · #2,622,311 worldwide 1k citations · 50 works
  2. 2 Dorothea Groß Germany · #4,202,526 worldwide 178 citations · 21 works
All ranked researchers at URSAPHARM (Germany)

What are the most cited papers from URSAPHARM (Germany)?

The most cited paper from URSAPHARM (Germany) is "Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices" (David E. Lefebvre, Koen Venema, Lourdes Gombau et al., 2014), with 142 citations. Next come "Chokeberry (Aronia melanocarpa (Michx.) Elliot) concentrate inhibits NF-κB and synergizes with selenium to inhibit the release of pro-inflammatory mediators in macrophages" (63) and "Placebo‐controlled Randomized Clinical Trial on the Immunomodulating Activities of Low‐ and High‐Dose Bromelain after Oral Administration – New Evidence on the Antiinflammatory Mode of Action of Bromelain" (59).

Most cited papers
#PaperReleasedCitations
1 Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices David E. Lefebvre, Koen Venema, Lourdes Gombau et al. · Nanotoxicology Open access 14 Aug 2014 142
2 Chokeberry (Aronia melanocarpa (Michx.) Elliot) concentrate inhibits NF-κB and synergizes with selenium to inhibit the release of pro-inflammatory mediators in macrophages Kurt Appel, Peter Meiser, Estrella Millán et al. · Fitoterapia 14 Jun 2015 63
3 Placebo‐controlled Randomized Clinical Trial on the Immunomodulating Activities of Low‐ and High‐Dose Bromelain after Oral Administration – New Evidence on the Antiinflammatory Mode of Action of Bromelain Silke C. Müller, R. März, Manfred Schmolz et al. · Phytotherapy Research Open access 20 Apr 2012 59
4 A Comparative Evaluation of Corneal Epithelial Cell Cultures for Assessing Ocular Permeability Ulrich J Becker, Carsten Ehrhardt, Marc Schneider et al. · Alternatives to Laboratory Animals Feb 2008 57
5 Proanthocyanidins: Oligomeric Structures with Unique Biochemical Properties and Great Therapeutic Promise Zhanjie Xu, Peng Du, Peter Meiser et al. · Natural Product Communications Open access Mar 2012 52
All 45 most cited papers, with filters and sorting

Which research topics does URSAPHARM (Germany) publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing and Allergic Rhinitis and Sensitization.

SARS-CoV-2 and COVID-19 …1SARS-CoV-2 and COVID-19 Research: 1 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksSARS-CoV-2 detection and testing: 0 fractional worksAllergic Rhinitis and Sensitization: 0 fractional worksRespiratory viral infections research: 0 fractional worksRetinal and Optic Condit…0Retinal and Optic Conditions: 0 fractional worksPickering emulsions and particle stabilization: 0 fractional worksAsthma and respiratory diseases: 0 fractional worksPeriodontal Regeneration and Treatments: 0 fractional worksExtracellular vesicles in disease: 0 fractional works
Infectious DiseasesImmunology and AllergyEpidemiologyOphthalmology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  2. 2 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  3. 3 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  4. 4 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  5. 5 Respiratory viral infections research Epidemiology 0 works
  6. 6 Retinal and Optic Conditions Ophthalmology 0 works
  7. 7 Pickering emulsions and particle stabilization Materials Chemistry 0 works
  8. 8 Asthma and respiratory diseases Physiology 0 works
  9. 9 Periodontal Regeneration and Treatments Urology 0 works
  10. 10 Extracellular vesicles in disease Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.3%not open39.7%

World: 40% of research is openly available.

with international co-authors25.1%domestic only74.9%

World: 18% is written across borders.

How has URSAPHARM (Germany)'s research output changed?

Output in 2022-2025 was 25% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is URSAPHARM (Germany) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.00010%0.00020%0.00030%URSAPHARM (Germany)0.000015% in 20251990200020102020

Fractional works of URSAPHARM (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Saarbrücken

All research institutions in Saarbrücken

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about URSAPHARM (Germany). Posts are plain text and can be reported.